Nitric oxide induced by tumor cells activates tumor cell adhesion to endothelial cells and permeability of the endothelium in vitro

Clinical and Experimental Metastasis

Volumn 15, Issue 6, 1997, Pages 557-567

  Yudoh, Kazuo ^a   Matsui, Hisao ^a   Tsuji, Haruo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Endothelial cells; Endothelial permeability; Nitric oxide; Tumor cell invasion

Indexed keywords

BETA1 INTEGRIN; CD15 ANTIGEN; DNA; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ARTICLE; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROSARCOMA; HUMAN; HUMAN CELL; MONOLAYER CULTURE; TUMOR CELL;

ANTIGENS, CD15; CAPILLARY PERMEABILITY; CELL ADHESION; CULTURE MEDIA, CONDITIONED; E-SELECTIN; ENDOTHELIUM, VASCULAR; FIBROSARCOMA; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; NEOPLASM INVASIVENESS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RECEPTORS, LYMPHOCYTE HOMING; TUMOR CELLS, CULTURED;

EID: 0030828922     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018487213157     Document Type: Article

References (41)

1. Liotta LA, 1986, Tumor invasion and metastases - role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res, 46, 1-7.
2. Crissman JD, Hatfield J, Menter DG, Sloane BF and Honn KV, 1988, Morphological study of the interaction of intravascular tumor cells with endothelial cells and sub-endothelial matrix. Cancer Res, 48, 4065-72.
3. Lapis K, Paku S and Liotta LA, 1988, Endothelization of embolized tumor cells during metastasis formation. Clin Exp Metastasis, 6, 73-89.
4. Volk T, Geiger B and Raz A, 1984, Motility and adhesive properties of high- and low-metastatic neoplastic cells. Cancer Res, 44, 811-24.
5. Nakajima M, Welch DR, Belloni PN and Nicolson GL, 1987, Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res, 47, 4869-76.
6. Yudoh K, Matsui H, Kamanori M, Ohmori K and Tsuji H, 1995, Tumor cell attachment to laminin promotes degradation of the extracellular matrix and cell migration in high-metastatic clones of murine RCT sarcoma in vitro. Jpn J Cancer Res, 86, 685-90.
7. Yudoh K, Matsui H, Kanamori A, Ohmori K, Tsuji H and Tatezaki S, 1994, Serum levels of laminin, type IV collagen and type III procollagen peptide as markers for detection of metastasis. Jpn J Cancer Res, 85, 1263-9.
8. Rice GE, Gimbrone MA Jr and Bevilacqua MP, 1988, Tumor cell-endothelial interactions: increased adhesion of human melanoma cells to activated vascular endothelium. Am J Pathol. 133, 204-10.
9. Bereta M, Bereta J, Cohen S, Zaifert K and Cohen MC, 1991, Effects of inflammatory cytokines on the adherence of tumor cells to endothelium in a murine model. Cell Immunol, 136, 263-77.
10. Nierodzik MLR, Kajumo F and Karpatkin S, 1992, Effects of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res, 52, 3267-72.
11. Bevilaqua MP, 1993, Endothelial-leukocyte adhesion molecules. Ann Rev Immunol, 11, 767-804.
12. Alon R, Fuhlbrigge RC, Finger EB and Springer TA, 1996, Interactions through L-selectin between leukocytes and adherent leukocytes nucleate rolling adhesions on selectins and VCAM-1 in shear flow. J Cell Biol, 135, 849-65.
13. O'Connor SW and Balf WF, 1984, Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors. Cancer Res, 44, 3719-23.
14. Gerlowski LE and Jain RK, 1986, Microvascular permeability of normal and neoplastic tissue. Microvasc Res, 31, 288-305.
15. Maeda H, Noguchi Y, Sato K and Akaike T, 1994, Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn J Cancer Res, 85, 331-4.
16. Palmer RMJ, Ferrige AG and Moncada S, 1987, Nitric oxide release accounts for the biological activity of endothelial-derived relaxing factor. Nature (London), 327, 524-6.
17. Martin W, Villani GM, Jothianandan D and Furchgott RF, 1985, Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther, 232, 708-16.
18. Dong Z, Staroselsky AH, Oi X, Xie K and Fidler IJ, 1994. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res, 54, 789-93.
19. Vidal MJ, Zocchi MR, Poggi A, Pellagatta F and Chierchia SL, 1992, Involvement of nitric oxide in tumor cell adhesion to cytokine-activated endothelial cells. J Cardiovasc Pharmacol, 20 (Suppl. 12), 155-9.
20. Hrabie JA, Klose JR, Wink DA and Keefer LK, 1993, New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem, 58, 1472-6.
21. Mooradian DL, Hutsell TC and Keefer LK, 1995, Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vivo. J Cardiovasc Pharmacol, 25, 674-8.
22. Kong L, Dunn GD, Keefer LK and Korthuis RJ, 1996, Nitric oxide reduces tumor cell adhesion to isolated rat postcapillary venules. Clin Exp Metastasis, 14, 335-43.
23. Kusama T, Nakamori S, Ohigashi H, et al. 1995, Enhancement of in vitro tumor-cell transcellular migration by tumor-cell-secreted endothelial-cell-retraction factor. Int J Cancer, 63, 112-8.
24. Utoguchi N, Mizuguchi H, Dantakean A, et al. 1996, Effect of tumor cell-conditioned medium on endothelial macromolecular permeability and its correlation with collagen. Br J Cancer, 73, 24-8.
25. Nicolson GL, 1989, Metastatic tumor cell interactions with endothelium, basement membrane and tissue. Curr Opin Cell Biol, 1, 1009-19.
26. a in the adhesion of pancreatic carcinoma cells to activated endothelium. Int J Cancer, 54, 972-97.
27. Kaji M, Ishikura H, KishimotoT, et al. 1995, E-selectin expression induced by pancreas-cancer-derived interleukin-1α results in enhanced adhesion of pancreas carcinoma cells to endothelial cells. Int J Cancer, 60, 712-17.
28. x oligosaccharide. J Cell Biol, 117, 895-902.
29. x determination on myeloid and tumor cells. Science, 250, 1132-35.
30. Takada A, Ohmori K, Takahashi N, et al. 1991, Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem Biophys Res Commun, 179, 713-19.
31. X antigen, is associated with metastatic potential of transitional cell carcinoma of the human urinary bladder. Biochem Biophys Res Commun, 181, 1218-22.
32. Groves RW, Allen MH, Ross EL, Ahsan G, Barker JN and MacDonald DM, 1993, Expression of selection ligands by cutaneous squamous cell carcinoma. Am J Pathol, 143, 1220-25.
33. Ignarro LJ, 1990, Biosynthesis and metabolism of endothelium-derived nitric oxide. Ann Rev Pharmacol Toxicol, 30, 535-60.
34. Moncada S, Palmer RMJ and Higgs EA, 1991, Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev, 43, 109-42.
35. Radomski MW, Palmer RMJ and Moncada S, 1990, Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA, 87, 10043-47.
36. Li L, Kilbourn RG, Adams J and Fidler IJ, 1991, Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res, 51, 2531-35.
37. Lepoivre M, Fieschi F, Coves J, Thelander L and Fontecave M, 1991, Inactivation of ribonucleotide reductase by nitric oxide. Biochem Biophys Res Commun, 179, 442-48.
38. Nakamura Y, Naito S, Ryuto M, et al. 1996, An in vitro invasion model for human renal cell carcinoma cell lines mimicking their metastatic abilities. Clin Exp Metastasis, 14, 466-74.
39. Leung DW, Cachianes G, Kuang WJ, Goeddel DV and Ferrara N, 1989, Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306-9.
40. Maruno N, Morita I, Shirano M and Murata S, 1992, IL-6 increases endothelial permeability in vitro. Endocrinol, 131, 710-14.
41. Mullin JM and Snock KV, 1990, Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res, 50, 2172-76.